China Biologic Products Inc (NASDAQ:CBPO)

During the Trading Day
96.84 +1.33 / +1.39%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
97.00 +0.16 / +0.17%
Volume: 724.00
Health Technology

Company Description

China Biologic Products, Inc. is the non-state-owned plasma-based biopharmaceutical company approved by the Chinese government. Through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products and Guiyang Dalin Biologic Technologies, and its equity investment in Xi'an Huitian Blood Products, the firm is a fully integrated provider of plasma-based biopharmaceuticals, with capabilities spanning from plasma collection to and research and development, to product manufacturing and commercialization. The firm's key products, human albumin and immunoglobin, are often used to treat life-threatening conditions, such as low albumin, hemophilia and other blood diseases. The firm has marketed plasma-based products and a pipeline of new products to drive future growth in the large Chinese plasma market. The company was founded on December 20, 1989 and is headquartered in Shandong Province, China.

Contact Information

China Biologic Products, Inc.
18/F, Jialong International Tower
Beijing Beijing 100125
Investor Relations:



Individual stakeholders93.22%
Other institutional8.50%
Mutual fund holders6.94%

Top Executives

David Xiaoying GaoExecutive Chairman, President & CEO
Ming YangCFO, Treasurer & Vice President-Compliance
Yi-Wu Vincent XieChief Technology Officer
Ming YinSenior Vice President
Zhijing CBPO LiuVice President

To view my watchlist

Not a member yet?

Sign up now for a free account